North Korea leader Kim Jong Un visited the bier of Kim at 2 a.m. on Wednesday to pay tribute "with bitter grief over the loss of a veteran revolutionary who had remained boundlessly loyal" to the ...
Donanemab has faced two separate regulatory delays in the United States, while a similar therapy by Eisai and partner Biogen, called Leqembi, received the U.S. Food and Drug Administration's approval ...
The patient, Rabindra Bishui, underwent the complex procedure to address a longstanding scalp swelling that had plagued him for over two decades, the AIIMS official said.
"An assault on Rafah would be a strategic mistake, a political calamity & a humanitarian nightmare," Guterres said in a video ...
According to media reports, AstraZeneca, an Anglo-Swedish drugmaker, has previously admitted in court documents that the vaccine causes side-effects such as blood clots and low blood platelet counts.
MTBVAC, the Spanish tuberculosis vaccine, the first live attenuated vaccine of Mycobacterium tuberculosis isolated from a human, reaches a new milestone by starting clinical trials in India, the most ...
Rebello said that the company has started centralising operations in the last six months to overcome the challenges of decentralised operations - how it was structured historically.
"Although Nifty opens positive, it is witnessing resistance at higher levels, indicating cautiousness among the investors with the progress of both the result season and the Lok Sabha election. We ...
The U.N. warned of a potential collapse of the flow of aid to Palestinians from the closure of Rafah and the other main crossing into Gaza, Kerem Shalom, at a time when officials say northern Gaza is ...
The United States stated on Tuesday that it has revoked certain licenses that permit companies to transport products, like ...
The new deadline is June 30, 2024. Investors need to have a nomination in place for their mutual fund schemes held in their folios or opt out of it by this date.
Queries emailed to Icertis founder Samir Bordas did not elicit a response till press time. A spokesperson for SoftBank India ...